Results 201 to 210 of about 900,095 (299)

Improvement in sequelae of chronic liver disease in patients with Alagille syndrome treated with maralixibat

open access: yesJPGN Reports, EarlyView.
Abstract Maralixibat (MRX) is an orally administered, small‐molecule ileal bile acid transporter (IBAT) inhibitor used in the treatment of cholestatic pruritus in conditions such as Alagille syndrome (ALGS). MRX's beneficial effects on cholestatic pruritus are well described, however its effects on patients’ clinical manifestations of hepatic disease ...
Tin Bo Nicholas Lam   +2 more
wiley   +1 more source

Carotid Artery Stenting

open access: yesJournal of the Society for Cardiovascular Angiography & Interventions
Jun Li   +26 more
openaire   +2 more sources

Examining the multivariate genetic architectures of posttraumatic stress disorder and cardiovascular disease phenotypes

open access: yesJournal of Traumatic Stress, EarlyView.
Abstract Posttraumatic stress disorder (PTSD) is associated with elevated cardiovascular disease (CVD) risk, but the extent of shared inherited liability is unclear. Large genome‐wide association studies (GWAS) allow for multivariate evaluation of common genetic architecture.
Shannon E. Cusack   +9 more
wiley   +1 more source

Long‐Term Clinical Response After Low‐Dose and Short‐Duration Cemiplimab Therapy in a Patient With Xeroderma Pigmentosum in Nepal

open access: yesJEADV Clinical Practice, EarlyView.
Capsule Summary Xeroderma pigmentosum (XP) is associated with a high risk of multiple and aggressive cutaneous squamous cell carcinomas (CSCCs). The immune checkpoint inhibitor cemiplimab has been approved in advanced, unresectable, and/or metastatic CSCCs.
Sudip Parajuli   +5 more
wiley   +1 more source

Early and long-term mechanical complications after carotid artery stenting. [PDF]

open access: yesJ Vasc Surg Cases Innov Tech
Keča V   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy